Glaxo Accord Said to Spur Lawyer Fight Over Fees
This article is for subscribers only.
GlaxoSmithKline Plc’s settlement of lawsuits over its Avandia drug triggered a challenge from nine law firms to a bid by lead attorneys for almost three-quarters of a $143 million fee fund, including one seeking about $2,700 per hour, according to two people familiar with the matter.
Attorneys suing on behalf of users of the diabetes medicine, who said it caused heart attacks and strokes, filed objections to the fee request in Philadelphia federal court, said the people, who asked not to be identified because the matter isn’t public. The contested amount is sought by a court-appointed group of plaintiffs’ lawyers picked to recommend how much attorneys in the cases should be paid, the people said.